Multiple primary cancer, including transitional cell carcinoma of the upper uroepithelial tract in a multigeneration HNPCC family

Molecular genetic, diagnostic, and management implications

Henry T. Lynch, Rodney J. Taylor, Jane F. Lynch, Joseph A. Knezetic, Ali Barrows, Riccardo Fodde, Juul Wijnen, Anja Wagner

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

OBJECTIVE: We report a multigeneration family where colorectal cancer and cancer of multiple diverse anatomic sites, inclusive of transitional cell carcinoma of the upper uroepithelial tract, were manifested in several relatives. METHODS: A specific pattern of cancer of the colorectum, endometrium, ovary, small bowel, and transitional cell carcinoma, with a vertical distribution of this cancer phenotype through multiple generations, was consonant with a diagnosis of hereditary nonpolyposis colorectal cancer. RESULTS: Germline mutation testing identified the MSH2 mutation, which segregated with the cancer phenotype. This family study clearly demonstrates the value of genetic testing in the management and treatment decision process. CONCLUSIONS: We document, perhaps for the first time, how molecular genetic testing in hereditary nonpolyposis colorectal cancer can aid in the identification of a potential renal transplant donor for a relative with the MSH2 mutation who is experiencing renal insufficiency secondary to transitional cell carcinoma.

Original languageEnglish
Pages (from-to)664-670
Number of pages7
JournalAmerican Journal of Gastroenterology
Volume98
Issue number3
DOIs
StatePublished - Mar 1 2003

Fingerprint

Molecular Pathology
Transitional Cell Carcinoma
Hereditary Nonpolyposis Colorectal Neoplasms
Molecular Biology
Genetic Testing
Phenotype
Neoplasms
Mutation
Small Cell Carcinoma
Germ-Line Mutation
Endometrial Neoplasms
Renal Insufficiency
Colorectal Neoplasms
Ovary
Tissue Donors
Kidney
Therapeutics

All Science Journal Classification (ASJC) codes

  • Gastroenterology

Cite this

Multiple primary cancer, including transitional cell carcinoma of the upper uroepithelial tract in a multigeneration HNPCC family : Molecular genetic, diagnostic, and management implications. / Lynch, Henry T.; Taylor, Rodney J.; Lynch, Jane F.; Knezetic, Joseph A.; Barrows, Ali; Fodde, Riccardo; Wijnen, Juul; Wagner, Anja.

In: American Journal of Gastroenterology, Vol. 98, No. 3, 01.03.2003, p. 664-670.

Research output: Contribution to journalArticle

Lynch, Henry T. ; Taylor, Rodney J. ; Lynch, Jane F. ; Knezetic, Joseph A. ; Barrows, Ali ; Fodde, Riccardo ; Wijnen, Juul ; Wagner, Anja. / Multiple primary cancer, including transitional cell carcinoma of the upper uroepithelial tract in a multigeneration HNPCC family : Molecular genetic, diagnostic, and management implications. In: American Journal of Gastroenterology. 2003 ; Vol. 98, No. 3. pp. 664-670.
@article{d5f99b47a8bd453c8ea9e9126c9140e5,
title = "Multiple primary cancer, including transitional cell carcinoma of the upper uroepithelial tract in a multigeneration HNPCC family: Molecular genetic, diagnostic, and management implications",
abstract = "OBJECTIVE: We report a multigeneration family where colorectal cancer and cancer of multiple diverse anatomic sites, inclusive of transitional cell carcinoma of the upper uroepithelial tract, were manifested in several relatives. METHODS: A specific pattern of cancer of the colorectum, endometrium, ovary, small bowel, and transitional cell carcinoma, with a vertical distribution of this cancer phenotype through multiple generations, was consonant with a diagnosis of hereditary nonpolyposis colorectal cancer. RESULTS: Germline mutation testing identified the MSH2 mutation, which segregated with the cancer phenotype. This family study clearly demonstrates the value of genetic testing in the management and treatment decision process. CONCLUSIONS: We document, perhaps for the first time, how molecular genetic testing in hereditary nonpolyposis colorectal cancer can aid in the identification of a potential renal transplant donor for a relative with the MSH2 mutation who is experiencing renal insufficiency secondary to transitional cell carcinoma.",
author = "Lynch, {Henry T.} and Taylor, {Rodney J.} and Lynch, {Jane F.} and Knezetic, {Joseph A.} and Ali Barrows and Riccardo Fodde and Juul Wijnen and Anja Wagner",
year = "2003",
month = "3",
day = "1",
doi = "10.1111/j.1572-0241.2003.07329.x",
language = "English",
volume = "98",
pages = "664--670",
journal = "American Journal of Gastroenterology",
issn = "0002-9270",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Multiple primary cancer, including transitional cell carcinoma of the upper uroepithelial tract in a multigeneration HNPCC family

T2 - Molecular genetic, diagnostic, and management implications

AU - Lynch, Henry T.

AU - Taylor, Rodney J.

AU - Lynch, Jane F.

AU - Knezetic, Joseph A.

AU - Barrows, Ali

AU - Fodde, Riccardo

AU - Wijnen, Juul

AU - Wagner, Anja

PY - 2003/3/1

Y1 - 2003/3/1

N2 - OBJECTIVE: We report a multigeneration family where colorectal cancer and cancer of multiple diverse anatomic sites, inclusive of transitional cell carcinoma of the upper uroepithelial tract, were manifested in several relatives. METHODS: A specific pattern of cancer of the colorectum, endometrium, ovary, small bowel, and transitional cell carcinoma, with a vertical distribution of this cancer phenotype through multiple generations, was consonant with a diagnosis of hereditary nonpolyposis colorectal cancer. RESULTS: Germline mutation testing identified the MSH2 mutation, which segregated with the cancer phenotype. This family study clearly demonstrates the value of genetic testing in the management and treatment decision process. CONCLUSIONS: We document, perhaps for the first time, how molecular genetic testing in hereditary nonpolyposis colorectal cancer can aid in the identification of a potential renal transplant donor for a relative with the MSH2 mutation who is experiencing renal insufficiency secondary to transitional cell carcinoma.

AB - OBJECTIVE: We report a multigeneration family where colorectal cancer and cancer of multiple diverse anatomic sites, inclusive of transitional cell carcinoma of the upper uroepithelial tract, were manifested in several relatives. METHODS: A specific pattern of cancer of the colorectum, endometrium, ovary, small bowel, and transitional cell carcinoma, with a vertical distribution of this cancer phenotype through multiple generations, was consonant with a diagnosis of hereditary nonpolyposis colorectal cancer. RESULTS: Germline mutation testing identified the MSH2 mutation, which segregated with the cancer phenotype. This family study clearly demonstrates the value of genetic testing in the management and treatment decision process. CONCLUSIONS: We document, perhaps for the first time, how molecular genetic testing in hereditary nonpolyposis colorectal cancer can aid in the identification of a potential renal transplant donor for a relative with the MSH2 mutation who is experiencing renal insufficiency secondary to transitional cell carcinoma.

UR - http://www.scopus.com/inward/record.url?scp=0037343935&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037343935&partnerID=8YFLogxK

U2 - 10.1111/j.1572-0241.2003.07329.x

DO - 10.1111/j.1572-0241.2003.07329.x

M3 - Article

VL - 98

SP - 664

EP - 670

JO - American Journal of Gastroenterology

JF - American Journal of Gastroenterology

SN - 0002-9270

IS - 3

ER -